NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
NCT01331005
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
125
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
nepafenac 0.1% drops
OTHER:
Nepafenac Vehicle
Sponsor
Jaeb Center for Health Research
Collaborators
[object Object]